Eric Hyllengren | Investor Relations |
Pascal Touchon | President and Chief Executive Officer |
Utpal Koppikar | Chief Financial Officer |
Joe Newell | Chief Operations Officer |
A.J. Joshi | Chief Medical Officer |
Marc Frahm | Cowen and Company |
John Newman | Canaccord Genuity |
Salim Syed | Mizuho Securities |
Yigal Nochomovitz | Citigroup |
Tony Butler | Roth Capital |
Andrea Tan | Goldman Sachs |
Ladies and gentlemen, thank you for standing by, and welcome to the Atara Biotherapeutics First Quarter 2020 Financial Results Conference Call. Please be advised that today's call is being recorded.
I would now like to hand the call over to Eric Hyllengren, Vice President of Investor Relations and Finance at Atara Biotherapeutics. Please go ahead, sir.
Thank you, Elaine.